- Abbvie Inc To Acquire Cerevel Therapeutics TranscriptDec 07, 2023
- Q3 2023 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptNov 01, 2023$25.35 (+7.19%)Earnings
- Cerevel Therapeutics Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptAug 02, 2023$26.33 (-14.09%)Earnings
- Cerevel Therapeutics Holdings Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptMay 03, 2023$31.92 (+3.32%)Earnings
- Cerevel Therapeutics Holdings Inc at Stifel CNS Days (Virtual) TranscriptMar 29, 2023
- Cerevel Therapeutics Holdings Inc at Cowen Health Care Conference TranscriptMar 06, 2023
- Q4 2022 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptFeb 22, 2023$26.73 (-13.77%)Earnings
- Cerevel Therapeutics Holdings Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptNov 08, 2022$25.7 (-5.20%)Earnings
- Cerevel Therapeutics Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptAug 01, 2022$27.66 (+5.21%)Earnings
- Q1 2022 Cerevel Therapeutics Holdings Inc Earnings Call TranscriptMay 10, 2022$22.68 (+2.25%)Earnings
- Cerevel Therapeutics Holdings Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Cerevel Therapeutics Holdings Inc at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2021
- Cerevel Therapeutics Holdings Inc R&D Event TranscriptJan 28, 2021
Q1 2023 Cerevel Therapeutics Holdings Inc Earnings Call Transcript
Good morning, and welcome to Cerevel Therapeutics First Quarter Financial Results Conference Call. (Operator Instructions) Please note that this call may be recorded.
I will now hand the call over to Matt Calistri, Vice President of Investor Relations.
Thank you. Good morning, everyone. We appreciate you joining us for our first quarter 2023 earnings call. On today's call, you'll be hearing from Dr. Tony Coles, our Chairperson and Chief Executive Officer; Dr. Ray Sanchez, our Chief Medical Officer; Dr. John Renger, our Chief Scientific Officer; and Mark Bodenrader, our Interim Chief Financial Officer.
During our call today, please refer to our press release from this morning detailing our first quarter 2023 performance, as well as our updated corporate presentation, both of which are available on our website. I would like to remind you that we will be making forward-looking statements that reflect our current views related to, among other things, the potential attributes and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)